Hepatoprotective effect of syringin combined with costunolide against LPS-induced acute liver injury in L-02 cells via Rac1/AKT/NF-κB signaling pathway
Figure 2.Effects of syr+cos on the cell viability of L-02 cells. Note: The data represent the mean ± SD per group. **P < 0.01 or *P < 0.05 vs control group; ##P < 0.01 vs LPS treatment group.